Rapt Therapeutics

compass map direction find trail north
Biotech

Rapt pays $35M for challenger to Novartis, Roche drug

Rapt Therapeutics has charted a new course following the implosion of its lead program, agreeing to pay $35 million for a long-acting rival to Xolair.
Nick Paul Taylor Dec 23, 2024 8:10am
FDA stop sign

Rapt's share price sinks after shelving AD drug under FDA hold

Nov 11, 2024 9:44am
image of a chain with a padclock keeping a gate closed

Rapt faces clinical hold after liver failure in immunology trial

Feb 20, 2024 10:42am
dusk parachute

Exscientia fires CEO—Chutes & Ladders

Feb 16, 2024 9:30am
a number of parachutes leaving an airplane

Moderna promotes Andres to new strategy role—Chutes & Ladders

Sep 30, 2022 9:30am
Close-up of handshake between person in suit and person in business shirt

Rapt edges into Asia with Hanmi I-O deal worth up to $118M

Dec 3, 2019 4:05pm